ANTISENSE OLIGONUCLEOTIDES MARKET ANALYSIS

Antisense Oligonucleotides Market, by Drugs (Pegaptanib, Eteplirsen, Mipomersen, and Others), By Therapeutic Application (Cancer, Diabetes, Ocular Diseases, Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy, Hemorrhagic Fever Viruses, HIV/AIDS, Cytomegalovirus Retinitis, and Others), by Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies), by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI1879
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Antisense Oligonucleotides Market Key Players:-

Key players in global antisense oligonucleotides market include Ionis Pharmaceuticals Inc., Sarepta Therapeutics Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Antisense Therapeutics Ltd., Isarna Therapeutics GmbH, Arrowhead Pharmaceuticals Inc., Atlantic pharmaceuticals Inc., Enzon Pharmaceuticals Inc., Bio-Path Holdings Inc., Glaxo smith Kline Plc., Gene Signal International SA., Geron Corporation, Gradlis Inc., ICO Therapeutics Inc., Aptose Biosciences Inc., Marina Biotech Inc., miRagen Therapeutics Inc., Synlogic Inc., OncoGenex Pharmaceuticals Inc., Pharmaxis Ltd., Rexahn Pharmaceuticals Inc., Regulus Therapeutics Inc., and Rxi Pharmaceuticals Inc.

ANTISENSE OLIGONUCLEOTIDES MARKET ANALYSIS

Leading Companies

Antisense Oligonucleotides Market Report Snapshots

EXISTING CLIENTELE